baber/WOPTO huggingface dataset:
Patent DK-40890-D0 (DK)
Inventor: HANSEN JOHN BONDO
IPC: C07D453/06
Filed: 1990-02-16
Abstract: New substituted urea compounds of formula I, or a pharmaceutically acceptable salt thereof:  (* CHEMICAL STRUCTURE *) I wherein A is  (* CHEMICAL STRUCTURE *)  wherein R3 is an oxadiazol, substituted with C1-8-alkyl, C2-8-alkenyl, C2-8 alkynyl, C3-7 cycloalkyl, benzyl, phenyl, C1-6-alkoxy, C1-6-alkylthio, amino or alkylamino; R2 is -H or lower alkyl; X is O or S; and R1 is a group of formula II, III, IV or V  (* CHEMICAL STRUCTURE *) II  (* CHEMICAL STRUCTURE *) III  (* CHEMICAL STRUCTURE *) IV  where n is 2 or 3, P is 1 or 2, q is 1 to 3, r is 1-3 and R4 and R5 are H,C1-7 alkyl or C3-6 cycloalkyl; and N-oxides thereof. The compounds are useful in pharmaceutical preparations for treating psychotic disorders, nausea and vomiting.
Patent DK-65585-D0 (DK)
Inventor: ARNOUX JEAN-CLAUDE
IPC: B65G47/08
Filed: 1985-02-12
Abstract: 1. A process for forming a load by stacking bags or boxes in horizontal layers, during the course of which process the bags are transported from a single bag supplying apparatus to a stacking table (21), the process comprising the following steps : a) at the outlet of the supply apparatus the bags are arranged in two lines (10, 11) along two sides of the stacking table ; b) these two lines are transferred onto the stacking table to form a layer ; c) the stacking table is lowered by a height corresponding to that of the said layer, then a further layer is formed ; and d) when the desired stack has been formed, it is ejected from the stacking table, the process being characterised in that the bags are arranged along two perpendicular sides of the stacking table without changing their orientation, and, a first line (10) being formed along a first side of the stacking table, a second line (11) is formed along the second side of the stacking table at the same time as the first line (10) is being transferred onto the stacking table, then the stacking table is rotated through 90 degrees and a fresh line (10) is formed along the first side of the stacking table at the same time as the second line (11) is being transferred onto the stacking table.
Patent DK-186583-D0 (DK)
Inventor: KIESEWETTER HOLGER
IPC: G01N15/10
Filed: 1983-04-27
Abstract: For measuring the deformation capacity of erythrocytes use is made of a sample vessel that is walled off into two spaces by a piece of foil with a pore therein. One such space is filled with buffer solution with erythrocytes and the other is filled with buffer solution without erythrocytes. A pressure head is produced acting across the foil for causing transit or passage of the erythrocytes through the opening, whose diameter is less than the major quiescent diameter of an erythrocyte so that information on the deformation capacity may be produced by measuring the transit time. This is done by electrodes placed on the two sides of the opening so that changes in the resistance to alternating current by an erythrocyte in transit may be sensed and the transit time taken. After about 200 transits the readings are processed in a processing unit.
Patent DK-231389-D0 (DK)
Inventor: BROWN EDWARD M
IPC: B65D41/18
Filed: 1989-05-11
Abstract: A container closure (122) comprises a cylindrical molded unitary member defining a top panel (122h) and a skirt depending from the top panel to an open end for securement to the container, the skirt being interiorly tapered (122f) at the open end. The taper begins flush with the outer surface of the skirt (122g) and ends in a first circumference extending radially of the central axis of such cylinder. The skirt further defines a bead (122d) extending radially interiorly of the skirt to a second circumference radially closer to the cylinder central axis than the first circumference. The closure provides sealing retention pressure in accordance with the radially interior extent of the bead and exhibits evidence of an initial removal from the container. In one embodiment, the bead is generally of semispherical configuration and flow passages (122d-1) may exist in the bead, preferably over less than the hemispherical extent thereof. In another embodiment; said skirt further defines front and rear locking tabs (220, 220A, 226) respectively mutually spaced perimetrically at a location above said tapered surface and a bead at a location below said top panel and said locking tabs. The method for making the closures involves the use of a stripper plate (118) to participate in part in defining a mold cavity.
Patent DK-437186-D0 (DK)
Inventor: GURTNER BERNARD
IPC: C07C67/307
Filed: 1986-09-12
Abstract: The invention relates to the synthesis of bromofluoroacetic acids of formula:   <IMAGE>   in which X is a hydrogen, fluorine, chlorine or bromine atom. These acids are prepared by reacting a compound of formula:   <IMAGE>  dissolved in concentrated hydrobromic acid, X having the same meaning as above and R representing a hydrogen atom or an alkyl or aryl radical, with gaseous hydrogen bromide.
Patent DK-466986-D0 (DK)
Inventor: EIGNER ERICH
IPC: C02F11/12
Filed: 1986-09-30
Abstract: Poultry droppings or similar pasty materials are dried and conditioned in two stages in the same vessel. In the first microbiological stage, the droppings are placed on elements carrying selective aerobic microorganisms to create optimum conditions. When the temp. drops, the second (flow-through) stage uses a many times greater air flow rate to dry out the material.
Patent DK-578985-D0 (DK)
Inventor: KELNER MAXIMILIAN
IPC: C12N9/18
Filed: 1985-12-13
Abstract: The present invention provides a process for obtaining cholesterol esterase by culturing an appropriate micro-organism in an appropriate nutrient medium and recovering the enzyme from the culture broth or from the biomass, wherein the culturing is carried out in a mineral salt medium containing n-alkanes with 10 to 20 carbon atoms as the sole source of carbon and in the form of an aerated submersion culture.
Patent DK-603683-D0 (DK)
Inventor: JANNEMANN THEO
IPC: F23D14/58
Filed: 1983-12-28
Abstract: PCT No. PCT/DE83/00076 Sec. 371 Date Dec. 27, 1983 Sec. 102(e) Date Dec. 27, 1983 PCT Filed Apr. 27, 1983 PCT Pub. No. WO83/03890 PCT Pub. Date Nov. 10, 1983.There is described here a gas water heater consisting of a blower (1), a premixing device (2), a gas burner (3), a heat exchanger (4), and a waste gas heat exchanger (5). Gas burner (3) works as super-stoichiometrically premixing burner and has a burner plate (9) which is cooled on the reverse side and which has a plurality of mixture passage openings (10). Heat exchanger (4) extends through two chambers (6, 7) which are located next to each other and through which waste gas flows in opposite directions. Condensation heat exchanger (5) works in the counter-current and consists of star-shaped section pieces through which heating water flows centrally and which are arranged vertically. Waste gas heat exchanger (5) and premixing device (2) run parallel to each other.
Patent DK-628284-D0 (DK)
Inventor: COUSIN MICHEL
IPC: C08G14/06
Filed: 1984-12-21
Abstract: In a process for hardening phenol-formaldehyde resol resins, comprising conducting the hardening of the resins with an acidic solution of water and/or an organic solvent having dissolved therein an aromatic sulphonic acid and/or concentrated sulphuric acid, the improvement comprising the hardening in the presence of aniline added to the phenolic resin beforehand in a quantity of between about 0.5 and 2% relative to the weight of the phenolic resin whereby the pot life is extended and the cure time is satisfactory, the resultant products being especially useful as prepegs.
Patent DK-675088-D0 (DK)
Inventor: FUNG YUEN KAI T
IPC: C12Q1/6886
Filed: 1988-12-02
Abstract: A Method of and a kit for detecting the predisposition to retinoblastoma. A method for detecting a defect in the retinoblastoma gene in retinoblastoma, osteosarcoma, fibrosarcoma, melanoma, soft tissue sarcoma, small-cell carcinoma and mammary tumors. The method includes hybridizing a retinoblastoma gene probe to DNA extracted from target tissue and then determining binding of the probe to the DNA. The target tissue can be tumor or non-tumor tissue and from a fetus to an adult. Further there are DNA probes of 4.6, 3.8, and 0.9 kb.
Patent HU-912140-D0 (HU)
Title: Fungicide preparations containing benzyl-ketones and process for the production of the active agents
Inventor: WINGERT HORST
IPC: C07C59/90
Filed: 1991-06-26
Abstract: Benzyl ketones of the formula  <IMAGE>  where X is CH or N, Y is O or NR4, R1, R2 are H or alkyl, R3 is halogen, cyano, nitro, alkyl, cycloalkyl, alkoxy, haloalkyl, arylalkyl, arylalkoxy, aryloxy or aryl, and the aryl groups in turn may be substituted, R4 is OH, alkoxy or arylalkoxy and R5 is H, methyl, halogen or methoxy, and fungicides containing these compounds.
Patent HU-902612-D0 (HU)
Title: Process for the preparation of 4-phenylmethyl-1h-indole derivatives
Inventor: CLEMENCE FRANCOIS
IPC: A61K31/404
Filed: 1990-04-27
Abstract: The invention relates to the products of general formula (I): 
<IMAGE>
 in which:
 R and R1, which may be identical or different, represent, in particular, H, alkyl, alkenyl or alkynyl, cycloalkyl or arylalkyl, optionally substituted, or, together, form a heterocycle which can contain a second heteroatom O, S or N, optionally substituted,
 A represents:
 (CH2)n with n = 2, 3, 4 or 5, or 
<IMAGE>
 X, Y, which may be identical or different, are H or OH or, together, form an oxo function,
 a, b, c, d are H or, together, form an oxo function or a double bond,
 Z represents, in particular, H, alkyl, alkenyl or alkynyl, cycloalkyl or arylalkyl, optionally substituted, or Z represents -R2-N(R3)(R4) where R2 is alkylene and R3 and R4 are R1 and R2 except for alkenyl and alkynyl,
 in all the possible isomeric forms and in the form of addition salts with inorganic or organic acids.
Patent NO-870597-D0 (NO)
Inventor: COLMAN DEREK ALAN
IPC: B04C/
Filed: 1987-02-16
Abstract: PCT No. PCT/AU86/00173 Sec. 371 Date Feb. 27, 1987 Sec. 102(e) Date Feb. 27, 1987 PCT Filed Jun. 17, 1986 PCT Pub. No. WO86/07548 PCT Pub. Date Dec. 31, 1986.This invention is about a cyclone separator. This separator may find application in removing a lighter phase from a large volume of a denser phase such as oil from water, with minimum contamination of the more voluminous phase. Most conventional cyclone separators are designed for the opposite purpose, that is removing a denser phase from a large volume of lighter phase, with minimum contamination of the less voluminous phase. In our case, a typical starting liquid-liquid dispersion would contain under 1% by volume of the lighter (less dense) phase, but it could be more.
Patent NO-872487-D0 (NO)
Inventor: DZUNG DACFEY
IPC: H04L27/20
Filed: 1987-06-15
Abstract: A method for transmitting digital data by means of continuous phase modulation (CPM), wherein the transmission signal s(t) is generated by retrieving stored digital values, which are allocated to a continuous sequence of symbols ai present at the transmitter input, from storage in a memory. In contrast to the conventional method, these stored digital values are not calculated from a predetermined frequency-base-band pulse g(t) by linear superposition but are optimized with respect to the in-band power emitted by means of an iterative method. This non-linear method leads to distinctly improved spectral characteristics of the transmission signal s(t).
Patent NO-873537-D0 (NO)
Inventor: HAARASILTA ASKO
IPC: A23K20/189
Filed: 1987-08-21
Abstract: A relatively dry, thermally stable, feed premix comprising a pelletized mixture of a physiologically acceptable carrier, for example, a grain flour, and one or more enzymes, is produced by mixing the ingredients, reacting the mixture to absorb the enzyme or enzymes into the carrier, and pelletizing the reacted mixture.
Patent NO-880470-D0 (NO)
Inventor: HEIM JUTTA
IPC: C12N15/60
Filed: 1988-02-03
Abstract: Recombinant DNA molecules coding for a pectin lyase expression system and derivatives thereof, such as the structural gene of PLI and corresponding regulatory sequences, e.g. promoter, signal and terminator sequences, and hybrid vectors comprising corresponding DNAs, including hybrid vectors with DNA coding for homologous or heterologous polypeptides, hosts, especially filamentous fungi, e.g. Aspergillus hosts, transformed by said vectors, methods for the preparation of said recombinant DNA molecules and said hosts and the use of the recombinant DNA molecules for the preparation of new expression systems. A further objective is the preparation of polypeptides by means of said DNAs and said hosts. <IMAGE>
Patent NO-880808-D0 (NO)
Inventor: LAMBERT DIDIER CHARLES
IPC: G01N33/28
Filed: 1988-02-24
Abstract: The octane number of a product is determined from its near infrared (NIR) absorption spectrum in the wave number spectral range from 6667 to 3840cm<-><1>. A number (n) of frequencies are selected within this range and the (n) absorbance values are correlated with the octane number by means of multivariate regression analysis.
Patent NO-900318-D0 (NO)
Inventor: DUROSS JAMES WIX
IPC: A23L27/30
Filed: 1990-01-23
Abstract: Free-flowing formations of spherules of loose knit microcrystals of the polymorphs of sorbitol sand mannitol are useful in fast-frozen food products as cryoprotectants due to their improved rate of solubility and dispersion. The free-flowing formations are also helpful in formulating confectionary and pharmaceutical products by improving processing efficiencies and texture and are useful in selected industrial applications as a result of their improved rate of solution and free-flowing characteristics.
Patent NO-900794-D0 (NO)
Inventor: DURBUT PATRICK
IPC: C11D1/29
Filed: 1990-02-20
Abstract: A light duty microemulsion liquid detergent composition, useful for removing greasy soils from surfaces with both neat and dilute forms of the detergent composition, includes a moderately water soluble complex of anionic and cationic surfactants, in which complex the anionic and cationic moieties are in essentially equivalent or equimolar proportions, an anionic detergent, a co-surfactant, an organic solvent and water. Preferably, the complex component is one in which the anionic and cationic moieties include hydrophilic portions or substituents, in addition to the complex forming portions thereof, the anionic detergent is a mixture of higher paraffin sulphonate and higher alkyl polyoxyethylene sulphate, the co-surfactant is a polypropylene glycol ether, a poly-lower alkylene glycol lower alkyl ether or a poly-lower alkylene glycol lower alkanoyl ester, and the organic solvent is a non-polar oil, such as an isoparaffin, or an oil having polar properties, such as a lower fatty acid ester or a lower fatty alcohol ester. Also within the invention are the described complex, preferably one of equimolar proportions of sodium C12-14 alkyl diethoxy ether sulphate and C12-14 alkyl-bis(2-hydroxyethyl) methylammonium halide, and processes for manufacturing the liquid detergent composition and for removing grease from laundry and hard surfaces by use of such a liquid detergent composition, especially in neat form, in which latter process significantly improved cleaning results, compared to that obtained when using control detergent compositions.
Patent NO-903231-D0 (NO)
Inventor: JAMES M R
IPC: A01N25/02
Filed: 1990-07-19
Abstract: A compound of the general formula <CHEM> or a salt or complex thereof, in which X, Y and Z are all optionally substituted carbon atoms and R is hydrogen, optionally substituted hydrocarbyl or acyl or -COOR<7> and R<7> is hydrocarbyl has anti-microbial properties. Particular examples are compounds in which X is -CH2 - or -C (CH3)2- and Y and Z are both -CH2- or X is is -CH2- and Y and Z are carbon atoms of a benzene ring. The zinc complexes have useful properties.
Patent NO-910613-D0 (NO)
Inventor: STOOR RALF
IPC: B29C45/14
Filed: 1991-02-15
Abstract: PCT No. PCT/FI89/00153 Sec. 371 Date Feb. 22, 1991 Sec. 102(e) Date Feb. 22, 1991 PCT Filed Aug. 23, 1989 PCT Pub. No. WO90/02038 PCT Pub. Date Mar. 8, 1990.A method for joining together tubular plastic products (1, 2) by heating the joint faces of the plastic products (1, 2) which have been chamfered at least partly in advance, and by passing molten plastic material into the space (4), that is formed between the opposite joint faces. The fixing of the tubular plastic products (1, 2) and the feed of the molten plastic material take place with the aid of a mold tool (5) which is applied onto the space (4), and molten plastic material is passed rapidly into the hollow space between the mold tool, (5) and the joint faces through a feed stub (6) provided in the mold tube.
Patent NO-932009-D0 (NO)
Inventor: QUENTIN-MILLET MARIE-JOSE
IPC: A61P31/04
Filed: 1993-06-02
Abstract: PCT No. PCT/FR92/00904 Sec. 371 Date May 25, 1993 Sec. 102(e) Date May 25, 1993 PCT Filed Sep. 29, 1992 PCT Pub. No. WO93/07172 PCT Pub. Date Apr. 15, 1993The present invention relates to the lower molecular weight subunit of the human transferrin receptor of a strain of N. meningitidis, in purified form, as well as to a vaccinal pharmaceutical composition intended for the prevention or attenuation of the effects of an N. meningitidis infection, containing the said subunit in purified form.
Patent NO-932392-D0 (NO)
Inventor: WEICHERT ANDREAS
IPC: C07C315/04
Filed: 1993-06-30
Abstract: Benzoylguanidines of the formula I <IMAGE>  with   R(1) equal to R(4)-SOm or R(5)R(6)N-SO2- with R(4) and R(5) equal to alk(en)yl, -CnH2n-R(7), and with R(7) equal to cycloalkyl or phenyl, where R(5) can also mean H, R(6) equals H or C1-C4-alkyl,   R(2) is hydrogen, (cyclo)alk(en)(yn)yl, aryl and hetaryl   R(3) is defined as R(2),  and their pharmaceutically tolerated salts, are described. Compounds I are obtained by reacting compounds of the formula II <IMAGE> with guanidine, in which L is a leaving group which can easily undergo nuclophilic substitution. Compounds I are outstandingly suitable as antiarrhythmic drugs with cardioprotective component for the treatment and prophylaxis of infarct and for treating angina pectoris, and they also greatly reduce preventively the pathophysiological processes in the development of ischaemia-induced damage. Furthermore, I are distinguished by a potent inhibitory action on cell proliferation. They can thus be used as antiatherosclerotics, remedies for the late complications of diabetes, cancers, fibrotic disorders such as pulmonary, hepatic or renal fibrosis. They are effective inhibitors of the cellular sodium-proton antiporter (Na<+>/H<+> exchanger).
Patent NO-934337-D0 (NO)
Inventor: PISCHEL DIETER A
IPC: B29C70/68
Filed: 1993-11-30
Abstract: PCT No. PCT/DE92/00434 Sec. 371 Date Apr. 18, 1994 Sec. 102(e) Date Apr. 18, 1994 PCT Filed May 28, 1992 PCT Pub. No. WO92/21512 PCT Pub. Date Dec. 10, 1992A process is disclosed for manufacturing an angular insulating wall element consisting of an angular rigid foam plate linked to brick fillets. Angular, one-piece fillets are space apart in a lying mold having an essentially V-shaped cross-section and the spacings between the fillets are filled with a mixture of san and isocyanate. Between the backs of the fillets and the sand and isocyanate mixture on the one hand and a countermold on the other hand is introduced a rigid foam layer, whereas part of the rigid foam partially impregnates the sand and isocyanate mixture. The areas of the mixture that are not impregnated with rigid foam are removed after curing the rigid foam layer. A molding box for carrying out this process is also disclosed.
Patent NO-942300-D0 (NO)
Inventor: SOERENSEN HANS HOLMEGAARD
IPC: A61K38/00
Filed: 1994-06-17
Abstract: A pharmaceutical preparation comprising a growth hormone and histidine or a derivative of histidine as additive or buffering substance shows a very high stability against deamidation, oxidation and cleavage of peptide bonds. The stability of the product allows for the storing and shipment thereof in a lyophilized state or in the form of a dissolved or re-dissolved preparation at ambient temperature. Crystallization of growth hormone in the presence of histidine or a derivative thereof gives rise to a higher yield of crystals having a higher purity than known methods.
Patent NO-950670-D0 (NO)
Inventor: VAZQUEZ MICHAEL L
IPC: C07C311/05
Filed: 1995-02-22
Abstract: Succinoylamino hydroxyethylamino sulfonamide compounds are effective as retroviral protease inhibitors, and in particular as inhibitors of HIV protease.
Patent NO-990935-D0 (NO)
Inventor: MATNI NADA EL
IPC: C08B37/00
Filed: 1999-02-26
Abstract: The invention concerns cross-linked copolymers with a base of non cross-linked polycarboxylic polymers, said copolymers containing at least one polycarboxylic polysaccharide. The invention also concerns a method for preparing these copolymers and their use in particular as support in pharmaceutical compositions.
Patent GB-0226523-D0 (GB)
Title: Electric motor driven hand-held tool
IPC: H01H9/06
Filed: 2002-11-14
Abstract: An electric motor driven hand-held tool, such as a drilling, hammering or screw driving tool having a tool housing within which is located an integrated switch unit (6). The switch unit (6) includes an electronic motor control unit (8), a first actuator which is actuated by a manually operable power member (4) and to which the control unit is responsive to power the motor and a second actuator (10) which is actuated by a manually operable forward/reverse member (14) and to which the control unit is responsive to drive the motor in a selected forward or reverse direction. The forward/reverse member (14) is located remotely from the switch unit (6) on a portion of the tool housing which can be seen by a user of the tool during normal operation of the tool. To facilitate this a linkage arrangement (16) is provided for actuating the second actuator (10) in response to a manual actuation of the forward/reverse member (14). The linkage (16) is pivotally mounted on a closed end of a jam pot motor casing (3). The linkage comprises a central annular portion (18) pivotally mounted on a boss (4) formed on the motor housing (3), a first upwardly extending arm (20) on which the forward/reverse lever (14) is formed and a second downwardly extending arm (22) which engages the second actuator (10). <IMAGE>
Patent GB-0229583-D0 (GB)
Title: A process for preparing duloxetine and intermediates for use therein
IPC: A61P25/24
Filed: 2002-12-19
Abstract: A process for making (+)duloxetine or an acid addition salt thereof, comprising reacting intermediate compounds of formulae (I) and (II) so as to yield a compound of formula (III), or an acid addition salt thereof in the presence of a base and a phase transfer catalyst, where one of X and Y is hydroxy and the other is a leaving group, and subjecting a compound of formula (III), or an acid addition salt thereof, to further process steps so as to yield (+) duloxetine, or an acid addition salt thereof, substantially free of (-)duloxetine.
Patent GB-0418625-D0 (GB)
Title: Liquid composition
IPC: C11D3/39
Filed: 2004-08-20
Abstract: A multi-chamber bottle comprises in one chamber a bleaching composition and in another chamber a bleach sensitive formulation. The viscosity of the bleaching composition is controlled by an admixture of a thickener and a hydrocarbon. The density of the bleaching composition is controlled by the presence of an ionic salt.
Patent GB-0424451-D0 (GB)
Title: Optical elements (II)
IPC: G02B26/02
Filed: 2004-11-05
Abstract: A variable focus (10) lens comprising a fluid chamber (12) containing a first fluid (14) and a second fluid (16) is disclosed. The fluids are non-miscible and in contact over a meniscus (18) and the second fluid is able to alter its shape on the influence of a magnetic field. The second fluid is preferably a ferrofluid. Means (20, 22) for applying a gradient magnetic field (24) over at least a part of the fluid chamber are provided that are capable of inducing a magnetic flux maximizing movement of the fluids, such that the shape of the meniscus varies in dependence on the magnetic field.